- Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
-
Ahn SY, Son SK, Lee GH, Kim I, Cheong JW, Lee WS, Kim BS, Jo DY, Jung CW, Seong CM, Lee JH, Yuh YJ, Kim MK, Ryoo HM, Park MR, Cho SH, Kim HG, Zang DY, Park J, Kim H, Lee S, Kim SH, Chang MH, Lee HS, Choi CW, Kwon J, Lim SN, Oh SJ, Joo I, Kim DW
- KMID: 2530879
- Blood Res.
- 2022 Jun;57(2):144-151.
- doi: 10.5045/br.2022.2021137
Background Nilotinib is a tyrosine kinase inhibitor approved by the Ministry of Food and Drug Safety for frontline and 2nd line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). This... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical features and outcomes of JAK2V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2V617F allele burden
-
Lee AJ, Kim SG, Nam JY, Yun J, Ryoo HM, Bae SH
- KMID: 2524084
- Blood Res.
- 2021 Dec;56(4):259-265.
- doi: 10.5045/br.2021.2021089
Background JAK2mutation status is a well-known risk factor for thrombosis in patients with myeloproliferative neoplasms. However, the clinical usefulness of JAK2V617F allele burden is under investigation. Methods We retrospectively evaluated the impact of... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy
-
Lee IH, Kang BW, Kim JG, Bae WK, Ki MS, Park I, Jo JC, Kim JY, Koh SA, Lee KH, Cho YY, Ryoo HM, Kwak SG, Lee JL, Lee SA
- KMID: 2501999
- Korean J Intern Med.
- 2020 Jan;35(1):185-193.
- doi: 10.3904/kjim.2018.064
Background/Aims: For metastatic renal cell carcinoma (RCC), various prognostic scoring systems have been developed. However, owing to the low prevalence of nonclear cell RCC, the three most commonly used tools... -
- CITED
-
- Close
- SHARE
-
- Close
- Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy
-
Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Hong S, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Lee KH, Kim JH
- KMID: 2454316
- Cancer Res Treat.
- 2019 Jul;51(3):1249-1256.
- doi: 10.4143/crt.2018.451
PURPOSE: The purpose of this study was to prospectively validate the Korean Cancer Study Group Geriatric Score (KG)-7, a novel geriatric screening tool, in older patients with advanced cancer planned... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer
-
Kim DW, Kim HG, Kim JH, Park K, Kim HK, Jang JS, Kim BS, Kang JH, Lee KH, Kim SW, Ryoo HM, Kim JS, Lee KH, Kwon JH, Choi JH, Shin SW, Hahn S, Heo DS
- KMID: 2437605
- Cancer Res Treat.
- 2019 Jan;51(1):119-127.
- doi: 10.4143/crt.2018.019
PURPOSE: This randomized phase III study was designed to compare the efficacy and safety of irinotecan plus cisplatin (IP) over etoposide plus cisplatin (EP) in Korean patients with extensive-disease small-cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Trans-differentiation via Epigenetics: A New Paradigm in the Bone Regeneration
-
Cho YD, Ryoo HM
- KMID: 2406234
- J Bone Metab.
- 2018 Feb;25(1):9-13.
- doi: 10.11005/jbm.2018.25.1.9
In regenerative medicine, growing cells or tissues in the laboratory is necessary when damaged cells can not heal by themselves. Acquisition of the required cells from the patient's own cells... -
- CITED
-
- Close
- SHARE
-
- Close
- An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer
-
Park IH, Sohn JH, Kim SB, Lee KS, Chung JS, Lee SH, Kim TY, Jung KH, Cho EK, Kim YS, Song HS, Seo JH, Ryoo HM, Lee SA, Yoon SY, Kim CS, Kim YT, Kim SY, Jin MR, Ro J
- KMID: 2388302
- Cancer Res Treat.
- 2017 Jul;49(3):569-577.
- doi: 10.4143/crt.2016.289
PURPOSE: Genexol-PM is a Cremophor EL–free formulation of low-molecular-weight, non-toxic, and biodegradable polymeric micelle-bound paclitaxel. We conducted a phase III study comparing the clinical efficacy and toxicity of Genexol-PM with... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Gastro-Gastric Intussusception Secondary to Primary Gastric Lymphoma
-
Jo HH, Kang SM, Kim SH, Ra M, Park BK, Kwon JG, Kim EY, Jung JT, Kim HG, Ryoo HM, Kang UR
- KMID: 2344491
- Korean J Gastroenterol.
- 2016 Jul;68(1):40-44.
- doi: 10.4166/kjg.2016.68.1.40
In adults, most intussusceptions develop from a lesion, usually a benign or malignant neoplasm, and can occur at any site in the gastrointestinal tract. Intussusception in the proximal gastrointestinal tract... -
- CITED
-
- Close
- SHARE
-
- Close
- POEMS syndrome misdiagnosed as bone metastasis in a patient with thyroid cancer
-
Baek SA, Ryoo HM, Bae SH, Cho YY, Kim SG, Kim GY, Kim MK
- KMID: 2319913
- Yeungnam Univ J Med.
- 2015 Dec;32(2):122-126.
- doi: 10.12701/yujm.2015.32.2.122
Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a monoclonal plasma cell disorder. Patients with POEMS syndrome also have various clinical manifestations including generalized edema, pleural effusion,... -
- CITED
-
- Close
- SHARE
-
- Close
- Myeloid Sarcoma of Peritoneum in Acute Myeloid Leukemia Patient with Inversion of Chromosome 16
-
Kim JY, Park BK, Bae SH, Ryoo HM, Sung WJ, Lee AJ
- KMID: 2268962
- Korean J Med.
- 2015 Nov;89(5):581-584.
- doi: 10.3904/kjm.2015.89.5.581
Myeloid sarcoma is an extramedullary myeloid neoplasm that usually involves the skin, soft tissues, and lymph nodes. Myeloid sarcoma is found in 2.5-9.1% of acute myeloid leukemia patients, usually those... -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Institutions, Correspondence, Figures & Legends Correction. Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner
-
Kang J, Boonanantanasarn K, Baek K, Woo KM, Ryoo HM, Baek JH, Kim GS
- KMID: 2164345
- J Periodontal Implant Sci.
- 2015 Aug;45(4):156-159.
- doi: 10.5051/jpis.2015.45.4.156
Some parts of published paper were misprinted. -
- CITED
-
- Close
- SHARE
-
- Close
- Hyperglycemia increases the expression levels of sclerostin in a reactive oxygen species- and tumor necrosis factor-alpha-dependent manner
-
Kang J, Boonanantanasarn K, Baek K, Woo KM, Ryoo HM, Baek JH, Kim GS
- KMID: 1824939
- J Periodontal Implant Sci.
- 2015 Jun;45(3):101-110.
- doi: 10.5051/jpis.2015.45.3.101
PURPOSE: Sclerostin, an inhibitor of Wnt/beta-catenin signaling, exerts negative effects on bone formation and contributes to periodontitis-induced alveolar bone loss. Recent studies have demonstrated that serum sclerostin levels are increased... -
- CITED
-
- Close
- SHARE
-
- Close
- A Novel Osteogenic Activity of Suberoylanilide Hydroxamic Acid is Synergized by BMP-2
-
Lee ZH, Kim HJ, Ryoo HM
- KMID: 2170088
- J Bone Metab.
- 2015 May;22(2):51-56.
- doi: 10.11005/jbm.2015.22.2.51
BACKGROUND: Many histone deacetylase (HDAC) inhibitors are well recognized as potential anti-cancer drugs. Inhibition of HDACs induces temporal transcription or epigenetic control, thus regulating many different biological responses. Here, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis
-
Hong J, Kim SJ, Ahn JS, Song MK, Kim YR, Lee HS, Yhim HY, Yoon DH, Kim MK, Oh SY, Park Y, Mun YC, Do YR, Ryoo HM, Lee JJ, Lee JH, Kim WS, Suh C
- KMID: 2132795
- Cancer Res Treat.
- 2015 Apr;47(2):173-181.
- doi: 10.4143/crt.2014.055
PURPOSE: This study was conducted to evaluate outcomes in adult patients with Burkitt lymphoma (BL) or Burkitt-like lymphoma treated with an rituximab plus hyper-CVAD (R-hyper-CVAD) regimen by focusing on tolerability... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Salvage Treatment for Isolated Brain Parenchymal Relapse due to Diffuse Large B Cell Lymphoma
-
Kim SG, Bae SH, Ryoo HM
- KMID: 2269156
- Korean J Med.
- 2015 Feb;88(2):218-223.
- doi: 10.3904/kjm.2015.88.2.218
A central nervous system (CNS) relapse is a rare but mostly fatal complication in patients with diffuse large B cell lymphoma (DLBCL). CNS involvement can occur as an isolated event... -
- CITED
-
- Close
- SHARE
-
- Close
- Relapsed plasmacytoma in central nervous system after complete remission of extramedullary plasmacytoma
-
Kang SM, Kim SG, Seo JH, Kim JY, Sung WJ, Bae SH, Ryoo HM
- KMID: 2319930
- Yeungnam Univ J Med.
- 2014 Jun;31(1):43-47.
Extramedullary plasmacytoma (EMP) is a rare disease that occurs in 3% to 5% of patients with plasma cell disorder. It occurs most commonly in the upper respiratory tract and the... -
- CITED
-
- Close
- SHARE
-
- Close
- Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea
-
Kim SJ, Cheong JW, Min YH, Choi YJ, Lee DG, Lee JH, Yang DH, Lee SM, Kim SH, Kim YS, Kwak JY, Park J, Kim JY, Kim HG, Kim BS, Ryoo HM, Jang JH, Kim MK, Kang HJ, Cho IS, Mun YC, Jo DY, Kim HY, Park BB, Kim JS
- KMID: 1796916
- J Korean Med Sci.
- 2014 Jan;29(1):61-68.
- doi: 10.3346/jkms.2014.29.1.61
We assessed the success rate of empirical antifungal therapy with itraconazole and evaluated risk factors for predicting the failure of empirical antifungal therapy. A multicenter, prospective, observational study was performed... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Dose Escalation with Single Opioid, Fentanyl Matrix in Patients Not Controlling Cancer Pain: A Multicenter, Prospective, Observational Study in Korea
-
Koh SA, Lee KH, Kim MJ, Lee KT, Park SW, Nam SH, Ryoo HM
- KMID: 2167636
- Cancer Res Treat.
- 2013 Dec;45(4):263-269.
PURPOSE: End-of-dose failure (EOD) is a clinically common observation and many cancer patients increase the frequency of opioid administration. Fentanyl matrix use is known to be effective in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement
-
Kang BW, Moon JH, Chae YS, Lee SJ, Kim JG, Kim YK, Lee JJ, Yang DH, Kim HJ, Kim JY, Do YR, Park KU, Song HS, Kwon KY, Kim MK, Lee KH, Hyun MS, Ryoo HM, Bae SH, Kim H, Sohn SK
- KMID: 2167616
- Cancer Res Treat.
- 2013 Jun;45(2):112-117.
PURPOSE: We investigated the clinical outcome of bone marrow (BM) involvement in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. MATERIALS AND METHODS: A total of 567 consecutive... -
- CITED
-
- Close
- SHARE
-
- Close
- Remission of Lymphocytic Interstitial Pneumonia in Sjogren's Syndrome after Autologous Peripheral Blood Stem Cell Transplantation
-
Choi HN, Choe JY, Kim SH, Kim SK, Ryoo HM, Park SH
- KMID: 2223037
- J Rheum Dis.
- 2013 Apr;20(2):118-122.
- doi: 10.4078/jrd.2013.20.2.118
Interstitial pneumonia occurs in approximately 25% of patients with primary Sjogren's syndrome. Interstitial pneumonia combined with primary Sjogren's syndrome usually responds well to systemic steroids, and fatal cases are rare.... -
- CITED
-
- Close
- SHARE
-
- Close
